Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Wednesday, November 29, 2023.
CRISPR Therapeutics AG - Common Shares (NASDAQ:CRSP)
Strong Uptrend (+100) - CRSP is in a strong uptrend that is likely to continue. With short-term, intermediate, and long-term bullish momentum, CRSP continues to climb. Traders should protect gains and look for a change in score to suggest a slow down in momentum.
Is it time to buy, sell, or avoid CRSP?
MarketClub looks at technical strength and momentum to determine if the timing is right for CRSP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CRSP
The long-term trend has been UP since Nov 7th, 2023 at 56.95
The intermediate-term trend has been UP since Nov 2nd, 2023 at 45.55
The short-term trend has been UP since Nov 14th, 2023 at 55.93
Smart Scan Analysis for CRSP
Based on our trend formula, CRSP is rated as a +100 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 70.7500 | 71.7399 | 69.4400 | 70.6800 | -0.9300 |
| Prev. Close | Volume | Bid | Ask | Time |
| 70.6600 | 1753679 | 2023-11-28 15:59:58 |
| Year High | 73.9 | Year High Date | 2018-05-24 |
| Year Low | 23.01 | Year Low Date | 2018-01-03 |
| 52wk High | 76.19 | 52wk High Date | 2023-11-20 |
| 52wk Low | 37.55 | 52wk Low Date | 2023-10-23 |
| Average Volume | 3,119,484 | Shares Outstanding | 79,432 |
| Market Cap | 2,616M | Assets | 208,683,000M |
| Liabilities | 359,036,000M | P/E Ratio | -8.27030000 |
| Volatility | 74.22 |